US buys 3.2 million doses of Novavax COVID-19 vaccineThe Biden administration announced this morning that it would buy 3.2 million doses of the Novavax COVID-19 vaccine, which is expected to soon receive authorization from the Food and Drug Administration, according to a Department of Health and Human Services (HHS) news release.The protein-based vaccine would be offered as a primary series of two shots.
If approved, it will be the fourth COVID-19 vaccine available to US adults.The 7-day average of new daily COVID-19 cases is 111,794, with 327 daily deaths and 38,149 hospitalized, according to the Washington Post tracker.
In the past week, new daily cases rose 6%, hospitalizations rose 11%, and deaths fell 14%.With COVID-19 cases in the city rising again, New York City public health officials late last week urged residents to return to mask-wearing in indoor public spaces, the Associated Press reports.In global news, the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency are recommending that second booster doses of COVID-19 vaccines be considered for people between 60 and 79 years old and people who have medical conditions putting them at high risk of severe disease."The updated recommendations come amid increasing rates of COVID-19 reporting and rates of hospital and intensive care unit (ICU) admissions and occupancy in several countries … and in the context of the emergence of the Omicron lineages BA.4 and BA.5.
These data signal that a new COVID-19 wave is ramping up across the European Union/European Economic Area (EU/EEA)," the ECDC said in a statement. Jul 11 HHS news release Jul 11 ECDC statementCOVID vaccine booster—not initial regimen—key for blood-cancer patientsMost